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ABSTRACT 
Objective: Chemometric optimization and validation of a HPLC method for the simultaneous determination of seven antihistamines viz., loratadine, 
fexofenadine, desloratadine, levocetirizine, doxylamine, promethazine and cinnarizine in bulk and their dosage form. 
Methods: Analytes were separated on Phenomenex cyano column by using ACN: MeOH: NH4OAc buffer as a mobile phase and peaks were detected 
at 220 nm. Optimization was performed in three steps: initially, fractional factorial design experiments were employed to eliminate parameters 
which were having an insignificant effect on responses. Significant variables: %ACN, pH and flow rate were incorporated in the central composite 
design and as the response variables, the retention factor (k1), resolution (Rs) of all seven investigated substances and retention time of last eluted 
peak (tR7) were studied. Finally, Derringer’s desirability function a global optimization technique was utilized to obtain ideal chromatographic 
conditions for a best possible combination of separation and analysis time.  
Results: The results were analyzed by using ANOVA for the establishment of an appropriate statistical relationship between the inputs and outputs. 
The predicted response values corresponding to the highest desirability value (D = 0.815) was selected. The optimized condition of %ACN: 
19.88%v/v, pH: 4 and flow rate of 1 ml/min was obtained through global optimization procedure. While using proposed condition up to seven 
antihistamines were separated in the same chromatogram with good resolution.  
Conclusion: The present study demonstrated the benefit of applying the chemometric approach in selecting optimum conditions for the 
simultaneous determinations of cited drugs in pharmaceutical formulations.  
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INTRODUCTION  
Drugs belonging to piperazine (levocetirizine, cinnarizine), 
piperidine (loratadine, desloratadine and fexofenadine), phenol-
thiazine (promethazine) and pyridine (doxylamine) are generally 
classified as antihistamines (H1 antagonist). These antihistamines 
inhibit the action of histamine in the body by blocking the receptors 
of histamine and effectively relieve from the symptoms of colds, 
rhinoconjunctivitis, urticaria and other allergic diseases [1]. Some of 
them viz., cinnarizine and promethazine are used to handle motion 
sickness, nausea, and vomiting. Furthermore, drugs like 
levocetirizine, loratadine, desloratadine and fexofenadine are 
classified as Rx to OTC switches [2]. Antihistamines are widely used 
in pharmaceutical formulation viz., tablets and syrups, etc. as single 
unit dose or in combination with other drugs in the Indian market. 
The chemical structure of loratadine (LRT), fexofenadine (FEX), 
desloratadine (DES), doxylamine (DOX), levocetirizine (LCT), 
promethazine (PRZ) and cinnarizine (CIN) are shown in fig. 1. 
Antihistamines are the most commonly prescribed medication for 
allergic rhinitis [3] as well as daily dermatologic practice, to adults and 
children [4]. Research and markets analyst reported the increasing 
demand of using systemic antihistamines and allergy medication [5]. 
To keep pace with these conditions, it is necessary to continue 
focusing research on quality assurance of these therapeutic substances 
and its dosage forms in order to have a wide safety margin and must 
bear understandable labelling to ensure proper use. 
In the literature, various liquid chromatographic methods (LC) have 
been reported for the determination of cited antihistamines. For 
instance, the HPLC method for the estimation of LRT [6], FEX [7-9], 
DES [10-13], LCT [14, 15], PRZ [16] and CIN [17] has been applied to 
bulk and their pharmaceutical dosage forms. However, an intensive 
literature survey revealed several other LC methods for multi-
component analysis of cited agents. For instance, a micellar 
electrokinetic chromatographic method was reported for the 
simultaneous determination of LRT and DES in pharmaceutical 
preparations and biological fluids [18]. 
 
 
Fig. 1: Structure of analytes 
 
Similarly, LC with a microemulsion as eluent was also described for 
the simultaneous determination of LRT and DES in pharmaceutical 
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preparations [19]. Capillary zone electrophoresis method was proposed 
for the simultaneous determination of LRT, DES and LCT [20].  
None of the aforesaid methods can be generalized, besides having 
other shortcomings. For example, the reported methods are not 
multi-purposeful, analysis of similar class drugs involving different 
chromatographic condition resulted in more consumption of organic 
solvents and reagents. Use of conventional C8 and C18 stationary 
phase separates compounds based mainly on their overall 
hydrophobicity. Some of the methods worth mentioning for 
simultaneous estimation are not simple and are based on gradient 
flow requiring robotic and complicated instrumentations, while 
many of the methods have been applied to a single component of 
this class (antihistamine) LRT, FEX, DES, LCT, PRZ and CIN are very 
common drugs of the antihistamine family available in many 
commercial pharmaceutical products either alone or in combination 
with other drugs, as is always the case in complicated health issues 
where multidrug therapy is in practice. To the best of author’s 
knowledge, there is no common analytical method that has been 
previously reported for the simultaneous analysis of cited 
antihistamines. Hence, the goal of the present study was to develop, 
optimize and validate an HPLC method for the simultaneous 
determination of piperazine (levocetirizine, cinnarizine), piperidine 
(loratadine, desloratadine, and fexofenadine), pyridine (doxylamine) 
and phenothiazine (promethazine) drugs present in commercial 
formulations and drug substances. 
The conventional trial and error based HPLC separation did not 
provide any possible information to track and predict the 
chromatographic behavior of analytes when multiple analytes are 
screened. The application of chemometric tool in liquid 
chromatography (LC) method development enables a thorough 
understanding of the investigated system and resolves complex 
optimization problems that are not achieved by a traditional change 
one-factor-at-a-time approach [21]. The use of certain chemometric 
tools viz., fractional factorial design (FFD), central composite design 
(CCD)-response surface methodology provides valuable data in 
order to evaluate the relationship between the studied factors and 
selected response [22]. In this way, the minimal experimental runs 
provides statistical data to investigate the separation behaviour of 
the analytes in the given experimental domain as well as to find 
optimum experimental conditions where the system generated 
desirable results by without performing the additional experiments.  
The present study demonstrates the utility of chemometric 
procedure for the optimization of chromatographic condition for the 
simultaneous estimation of seven antihistamines. In this study, 
retention factor, the resolution between adjacent peaks and analysis 
time were screened. To evaluate all these responses simultaneously, 
Derringer’s desirability function a global optimization technique 
[23] was utilized to obtain ideal chromatographic conditions for a 
best possible combination of separation and analysis time for 
regular quality control analysis of cited antihistamines.  
MATERIALS AND METHODS 
Standards and reagents  
Working standards of LRT, FEX, DES, DOX and CIN was procured 
from Yarrow Chemical Ltd, Mumbai, India. LCT was kindly donated 
by M/S. Sunglow Pharma, Puducherry, India. PMZ was kindly 
provided by Pharmssan Pharmaceuticals, Tiruchi, Tamil Nadu, India. 
Acetonitrile (ACN) and methanol (MeOH) were of HPLC grade and 
purchased from M/S SD Fine chemicals, Mumbai, India. Ammonium 
acetate (NH4OAc) analytical grade (AR) was procured from Fischer 
Chemic Ltd, Chennai, India. Acetic acid was of analytical grade 
purchased from Spectrochem, Mumbai, India.  
High purity HPLC water was prepared by passing through a 
Millipore Milli-Q plus system (Millipore, Bangalore, India) and was 
used to prepare buffer solutions. The pharmaceuticals: Lorfast Mel 
tab (10 mg of LRT), Allegra 120 tab (120 mg FEX), Deslor 5 mg tab 
(5 mg DES), Vozet 5 tab (5 mg LCT), Phenergan 10 mg tab (10 mg 
PRZ) and Stugeron 25 mg tab (25 mg CIN) were procured from local 
pharmacy shop and evaluated for the amount present in the 
formulation. 
Instrumentation and chromatographic condition 
The chromatographic method development and validation were 
performed on Shimadzu HPLC (Shimadzu Corporation, Kyoto, 
Japan). The system consisted of two LC 20 AD solvent delivery 
modules, an SPD-M 20A PDA detector and a Rheodyne injector 
(model 7125, USA) valve fitted with a 20-μl loop. The system was 
controlled by a system controller (SCL-10A) and a personal 
computer using a Shimadzu chromatographic software (LC Solution, 
Release 1.11SP1) installed on it. Absorbance spectra were recorded 
using a UV-Visible spectrophotometer (Model UV-1601PC; Japan) 
using quartz cell of 1.00 cm path length. The chromatographic 
separations were carried out on a Phenomenex cyano analytical column 
(150 mm x 4.6 mm i.d., 5 µm) connected with a Phenomenex cyano 
guard cadridge (4 mm x 3 mm i.d., 5 µm). The mobile phase consisted of 
ACN: MeOH: NH4OAc buffer (pH 4.0) adjusted with acetic acid. Prior to 
use, the mobile phase was degassed for 15 min in an ultrasonic bath and 
vacuum filtered through a 0.45-μm membrane filter (Gelman Science, 
India). The wavelength of 220 nm (isosbestic point) was selected for 
detection. An injection volume of the sample was 20 µl. The HPLC system 
was used in an air conditioned laboratory atmosphere (20±2ºC). 
Software tools employed 
Experimental design, data analysis, and desirability function 
calculations were performed by using Design expert®, 8.0 version 
(Stat-Ease, MN, USA). Sensitivity plot and prediction plot was 
generated using JMP®, 9.0 trial version (SAS Institute Inc., Cary, NC). 
The rest of the calculations were performed using Microsoft Excel 
2010 software (Microsoft, USA). 
Preparation of the standard solution  
A stock solution (1 mg/ml) of LRT, FEX, DES, LCT, PRZ, CIN and DOX 
was prepared separately by dissolving 10 mg of each in a 10 ml 
volumetric flask using MeOH as diluent. DOX (fig. 1) was used as an 
internal standard (IS) as it presented acceptable resolution and 
retention time with all these analytes. From this stock solution, a 
mixture of working standard solution of 10 mg/ml strength was 
prepared by transferring 100 µl of each stock solution into a 10 ml 
volumetric flask using mobile phase as diluents. This mixture was 
considered as 100% solution. These stock solutions were stored at 
approximately 5ºC and were found to be stable for several weeks. 
Preparation of the sample solution for the assay of tablets 
The developed HPLC method was used for the determination of 
selected drugs in pharmaceutical formulations. Marketed 
formulations viz., brand name: Lorfast Mel tab (10 mg of LRT), 
Allegra 120 tab (120 mg FX), Deslor 5 mg tab (5 mg DEL), Vozet 5 
tab (5 mg LCT), Phenergan 10 mg tab (10 mg PRZ) and Stugeron 25 
mg tab (25 mg CIN) were evaluated for the amount present in the 
formulation. Twenty tablets of each were weighed and powdered 
separately. Accurately measured powder equivalent to 10 mg of 
each drug was transferred separately into each 10 ml volumetric 
flask containing 5 ml of the diluent (MeOH). Then the resulted 
solution of each was sonicated for 15 min to ensure complete 
solubility of the drugs. Finally, the volume was adjusted up to 10 ml 
with the same diluent. Further dilutions were made to obtain a 
concentration of LRT, FEX, DES, LCT, PRZ, CIN and DOX (IS) as 5, 12, 
5, 5, 10, and 25 µg/ml) respectively. The resulted solution was 
centrifuged at 4000 rpm for 10 min; the clear supernatant was 
collected and filtered through a 0.2 µm membrane filter (Gelman 
Science, India) and 20 µl of this solution was injected for HPLC 
analysis in the presence of doxylamine (10 μg/ml) as IS. 
Method validation 
The analytical performance parameters such as linearity, precision, 
accuracy, limit of detection, limit of quantification, specificity and 
robustness were validated according to ICH Q2 (R1) guidelines [24]. 
RESULTS AND DISCUSSION 
Initial screening 
A set of initial experiments were performed to decide the basic 
analytical requirements for the simultaneous analysis of LRT, FEX, 
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DES, LCT, PRZ, CIN and DOX (IS). The performance of three 
analytical columns viz., Phenomenex monolithic C18 (100 mm x 4.6 
mm id.), Phenomenex phenyl-hexyl (150 mm x 4.6 mm id, 5 µm) and 
Phenomenex cyano (100 mm x 4.6 mm i.d. 5 µm) was tested. The 
better selectivity and peak separation were obtained with cyano 
column by using the mobile phase consisting of a ternary solvent 
mixture of ACN-MeOH-NH4OAc buffer. Formic acid and acetic acid 
were tested as buffer pH modifier. It was observed that the better 
separation and peak shape were obtained when acetic acid was used 
as pH modifier. In order to achieve a quality separation, it is 
important to identify the factors that need to be optimized for 
acceptable retention band spacing (either to maximize or to 
minimize) in a short analysis time on the cyano column.  
Optimization stage 
The goal of the optimization stage was to establish an optimal 
condition in which all analytes separate from each other in a short 
analysis time. The factors are predominantly affecting peak 
resolution and the analysis time was selected for the further 
optimization design. Before starting on optimization procedure, it is 
important to identify the significant factor using fractional factorial 
design (FFD) with center points in order to eliminate parameters 
which were having an insignificant effect on selected responses. For 
instance, the percentage ACN in the mobile phase resulted in better 
separation and elution strength when to compare to MeOH hence, 
ACN (factor A) being selected as the organic modifier in the mobile 
phase. On the other hand, the pH range (factor B) and buffer 
concentration (factor C) are other key factors in separation 
procedure when multiple compounds to be analyzed. Therefore, pH 
and buffer concentration were selected to test their role an analyte 
separation. Finally, mobile phase flow rate (factor D) was selected to 
investigate the effect on the time of analysis. The factor space of this 
design was expanded within the following range: %ACN 
concentration (15-25%v/v), pH (3.5-4.5), buffer Strength (30-50 
mM), and flow rate (0.8-1.2 ml/min) with the fixed concentration of 
MeOH (40% v/v). The rest of the volume of mobile phase was 
constituted by NH4OAc buffer solution.  
The experimental results of the FFD were fitted with a first-order 
model. The significance of each factor was determined by using 
analysis of variance (ANOVA). ANOVA generated for 2[4-1] 
fractional factorial design (FFD) showed that curvature was 
significant for %ACN, pH and flow rate except for buffer 
concentration. In order to gain a better understanding of the results, 
the predicted models are presented in fig. 2 as sensitivity plot. This 
type of plots demonstrates the effect of an independent factor on a 
specific response, with all other factors kept constant at a reference 
point. A triangle twist in a factor indicates that the response is 
sensitive to that factor. Based on the results obtained from 2[4-1] 
FFD, the key factors selected for further optimization process were A 
(%ACN v/v), B (pH), and D (flow rate). This implied that quadratic 
model should be considered to model the separation process. In 
order to obtain the second order predictive model, central 
composite design (CCD)-a design type under response methodology 
was employed. CCD was chosen due to its flexibility, and it could be 
applied to optimize an HPLC separation by gaining a better 
understanding of factor’s main and interaction effects. In the 
optimization design, additional experiments (axial points) were 
incorporated into the two-level factorial design to obtain a CCD.  
 
 
Fig. 2: JMP sensitivity plot for 24-1 fractional factorial design 
experiments and showing the effect of each of the independent 
factors of ACN volume, buffer concentration, pH and flow rate 
on: k1, Rs1,2-Rs6,7, and tR7
 
Table 1: Experimental design and results of the 24-1 fractional factorial design 
Run Factors Responses 
 %A B. S pH FR k1 Rs1,2 Rs2,3 Rs3,4 Rs4,5 Rs5.6 Rs6,7 tR7 
1. 15 30 3.5 0.8 0.966 3.11 1.71 1.58 1.34 1.93 9.93 12.32 
2. 25 30 3.5 1.2 0.501 2.13 4.72 2.63 1.21 1.22 3.31 5.59 
3. 15 30 4.5 1.2 0.892 5.04 3.42 4.66 4.34 2.54 9.61 17.88 
4. 25 30 4.5 0.8 0.523 1.95 9.37 12.1 2.95 2.31 2.92 15.92 
5. 15 50 3.5 1.2 0.857 2.67 1.04 1.46 0.91 1.68 8.42 7.02 
6. 25 50 3.5 0.8 0.467 2.11 3.49 2.51 1.24 1.68 3.91 6.91 
7. 15 50 4.5 0.8 0.862 5.65 1.45 3.82 4.48 2.81 10.2 20.88 
8. 25 50 4.5 1.2 0.502 1.58 5.28 7.97 2.31 1.99 2.36 7.63 
9. 20 40 4.0 1.0 0.641 3.49 4.25 3.05 2.52 1.95 6.25 8.79 
10. 20 40 4.0 1.0 0.633 3.53 4.24 3.04 2.53 1.96 6.31 8.69 
11. 20 40 4.0 1.0 0.652 3.47 4.23 3.05 2.49 1.95 6.19 8.65 
12. 20 40 4.0 1.0 0.665 3.47 4.22 3.05 2.49 1.95 6.19 8.71 
% A: ACN concentration (v/v); B. S: Buffer strength (mM); FR: Flow rate (ml/min) 
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Table 1 shows the levels of each factor studied for finding out the 
optimum values and responses. The ranges of each factor used were 
ACN concentration (15-25%v/v), buffer pH (3.5-4.5) and flowed rate 
(0.8-1.2 ml/min). Since the factor C (buffer strength) was not 
significant, it was fixed at the corresponding center value (40 mM) of 
the FFD.  
As response variables, the retention factor for the first eluted peak 
LRT (k1), the resolution between peaks Rs1,2 to Rs6,7 and the retention 
time of the last peak tR7 were selected. For an experimental design 
with the three factors, including linear, quadratic and cross terms, 
the model can be expressed as 
Y = β0+β1X1+β2X2+β3X3+β12X1X2+β13X1X3+β23X2X3+β11X12+β22X22+β33X32 
Where, Y is the response to be modelled, β is the regression 
coefficient and X1, X2 and X3 represent factors A (ACN), B (pH) and 
C (flow rate) respectively. Table 2 summarizes the conducted 
experiments, viz. (n = 14+6) six replicates at the center point and the 
responses. All experiments were conducted in randomized order to 
minimize the effects of uncontrolled variables that may introduce a 
bias on the measurements. Statistical parameters obtained from 
ANOVA for the reduced models were given in table 3. The insignificant 
terms (p>0.05) were eliminated from the model through a backward 
elimination process to obtain a simple and realistic model.  
 
Table 2: Design of experiments and results of the central composite designa 
Run Factors Responses 
 %ACN pH FR k1 Rs1,2 Rs2,3 Rs3,4 Rs4,5 Rs5.6 Rs6,7 tR7 
1. 28.41 4.0 1.0 0.413 0.89 7.11 5.63 1.33 1.38 1.57 6.71 
2. 15 3.5 0.8 0.889 1.01 1.21 1.43 1.60 1.84 3.59 11.07 
3. 25 3.5 1.2 0.510 1.92 3.61 2.48 1.10 1.20 3.21 4.73 
4. 15 4.5 1.2 0.847 4.61 2.32 4.11 4.04 2.41 9.15 14.67 
5. 25 4.5 0.8 0.440 1.55 7.15 9.31 2.60 2.16 2.83 12.07 
6. 15 3.5 1.2 0.888 0.94 1.34 1.09 1.15 1.61 8.38 7.17 
7. 25 3.5 0.8 0.486 2.25 4.27 2.96 1.30 1.44 3.74 7.07 
8. 15 4.5 0.8 0.853 5.27 2.16 3.94 4.42 2.67 10.2 21.15 
9. 25 4.5 1.2 0.444 1.32 6.24 8.20 2.27 1.90 2.47 8.05 
10. 20 4.0 1.0 0.598 3.35 3.68 2.51 2.35 1.78 5.96 8.61 
11. 20 4.0 1.0 0.597 3.08 3.72 2.53 2.35 1.79 6.03 8.65 
12. 20 4.0 1.0 0.598 3.03 3.64 2.47 2.32 1.77 5.97 8.66 
13. 20 4.0 1.0 0.620 3.04 3.64 2.47 2.33 1.78 6.01 8.68 
14. 20 4.0 1.34 0.733 2.79 3.19 2.17 2.11 1.59 5.47 6.50 
15. 20 4.0 0.66 0.610 3.58 4.28 2.98 2.53 1.99 6.52 12.95 
16. 11.59 4.0 1.0 1.149 5.28 1.64 0.71 1.29 2.06 11.2 15.52 
17. 20 3.16 1.0 0.620 0.58 1.51 1.15 1.35 0.96 4.30 5.43 
18. 20 4.84 1.0 0.586 2.94 4.42 10.7 3.66 2.64 5.66 15.11 
19. 20 4.0 1.0 0.622 3.01 3.62 2.48 2.34 1.77 6.02 8.69 
20. 20 4.0 1.0 0.624 3.02 3.64 2.44 2.32 1.78 6.04 8.68 
arandomized 
 
Table 3 shows that the adjusted R2 values were well within the 
acceptable limits of R2 ≥ 0.80, which revealed that the experimental 
data showed a good fit with second order polynomial equations. For 
all the reduced models p value<0.05 was obtained, implying these 
models were significant. The adequate precision value is a measure 
of the signal (response) to noise (deviation) ratio. A ratio greater 
than 4 is desirable. The ratio was found to be in the range from 
15.86 to 71.76 which indicated an adequate signal and therefore the 
model was significant for the separation process. From the 
polynomial equations (summarized in table 3) positive interaction 
terms indicate the combined effect of independent variables on 
response variables. As in the case of response Rs2,3 and Rs3,4 one of 
the interaction terms were positive, i.e., the effect of concentration of 
ACN and pH. Similarly for tR7 interaction term was positive for ACN 
and flow rate. In order to gain a better understanding of the results, 
the predicted models are presented in fig. 3 as JMP prediction plot. 
This type of plots demonstrates the effect of an independent factor 
on a specific response, with all other factors kept constant at a 
reference point. A steep slope or curvature in a factor indicates that 
the response is sensitive to that factor. 
ACN concentration increases that resulted decline in the retention 
factor of the first eluted peak k1. It was interesting to note that 
decreasing the level of pH significantly distorted the resolution of 
Rs1,2 to Rs5,6. The existence of such interactions emphasized the 
necessity to carry out active multifactor experiments for the 
optimization of chromatographic separation. The selected responses 
were not affected in the same manner with the changes in 
experimental parameters, it was necessary to arrive a best possible 
combination of good baseline separation and runtime. 
Global optimization  
The selected responses were not affected in the same manner with 
the changes in experimental parameters; hence, it was necessary to 
strike a right balance to arrive a quality separation. Derringer’s 
desirability function (D) was employed for global optimization of 
selected responses and to identify the optimal conditions for the 
regular quality control analysis of selected antihistamines. The 
expression that defines the Derringer’s desirability function is:  
D = [d1p1x d2p2x d3p3x. . xdnpn]1/n 
 
Table 3: Reduced response models and statistical parameters obtained from ANOVA 
Response Reduced response model Adjusted R2 Model P value %CV Adequate precision 
k1 k1 =+0.60-0.21A-0.018B+0.017C+0.058A2+0.019C2 0.9830 0.000 3.70 52.564 
Rs1,2 Rs1,2=+3.05-0.90A+0.78B-1.15AB-0.53B2 0.9058 0.000 15.88 23.925 
Rs2,3 Rs2,3 =+3.66+1.72A+0.90B-0.23C+0.45AB-0.23AC+0.22A2-0.28B2 0.9921 0.000 4.23 60.158 
Rs3,4 Rs3,4 =+2.53+1.51A+2.47B+0.82AB+0.29A2+1.26B2 0.9745 0.000 12.33 38.854 
Rs4,5 Rs4,5 =+2.46-0.28A+0.88B-0.40AB-0.32A2 0.8404 0.000 16.57 15.868 
Rs5,6 Rs5,6 =+1.83-0.22A+0.43B-0.12C 0.9466 0.000 5.46 34.464 
Rs6,7 Rs6,7 =+5.73-2.59A+0.59B-1.13AB 0.8329 0.000 18.22 18.649 
tR7 tR7 =+8.68-2.70A+3.09B-2.02C-1.16AB+0.50AC-
0.53BC+0.92A2+0.62B2+0.43C2 
0.9944 0.000 3.07 71.757 
Kanthiah et al. 




Fig. 3: JMP plot for central composite design experiments showing the effect of selected factors of ACN volume, pH and flow rate on: k1, 
Rs1,2-Rs6,7, and tR7 
 
The characteristics of goal may be altered by adjusting the 
importance or weight. Weights lower than 1 give less emphasis to 
the goal, whereas weights greater than 1 give more emphasis to the 
goal. As can be seen from table 2, retention factor of the first peak 
(k1) was kept at a maximum. On the other hand, resolutions between 
peaks were targeted to two and finally the retention time of the last 
peak was kept at a minimum in order to shorten the analysis time. 
Importance can range from 1 (the least important) to 5 (the most 
important), which gives emphasis to targeted value. For instance, 
high importance value of 4 was assigned to first eluting peak (k1) to 
avoid overlapping with noise peak, and tR7 to shorten analysis time 
that are usually preferred for routine analysis. Following the 
conditions and restrictions above, the optimization procedure was 
carried out. The predicted response values corresponding to the 
highest desirability value (D = 0.815) was selected. The response 
surface graph obtained for the global desirability function is 
presented in fig. 4. The coordinates producing the maximum 
desirability value were ACN concentration of 19.88%v/v, buffer pH 
of 4 and flow rate of 1 ml/min. The predicted response values 
corresponding to the latter value of D were k1 = 0.609, Rs1,2 to Rs6,7 
viz., 3.067, 3.599, 2.500, 2.472, 1.821 and 5.792 respectively and tR7 
= 8.6 min. The prediction efficiency of the model was confirmed by 
performing the experiment under the optimal condition, and the 
corresponding chromatogram is shown in fig. 5(b). The average 
errors of k1, Rs1,2 to Rs6,7 and tR7 were within a difference of<4%, 
indicating a good correlation found between the experimental and 
the predicted responses. 
 
 
Fig. 4: Graphical representation of the overall Desirability 
function D. %ACN (A) is plotted against pH (C) with constant 
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Assay method validation 
Validation of the optimized method was performed by following ICH 
guidelines to ensure adequate selectivity, linearity, precision, 
accuracy, limit of detection (LOD), limit of quantitation (LOQ) and 
robustness. Selectivity of the method was assessed by comparing the 
chromatograms of placebo sample containing a mixture of the 
commonly used excipients (starch, lactose monohydrate, 
hydroxypropyl methylcellulose, titanium dioxide and magnesium 
stearate) with that of selected analytes; no interfering peaks were 
noticed in the chromatogram. The respective chromatogram was 
shown in fig. 5(a). The linearity was established by analyzing five 
working solutions of LRT (2-10 µg/ml), FEX (5-25 µg/ml), DES (2-10 
µg/ml), LCT (2-10 µg/ml), PRZ (4-20 µg/ml) and CIN (5-50 µg/ml) 
corresponding to 20-200 % of expected test concentration for 
quality control of LRT, FEX, DES, LCT, PRZ and CIN tablets. 
Calibration curves were plotted using peak area ratios of all the 
analytes. The obtained regression equations for LRT, FEX, DES, LCT, 
PRZ and CIN are summarized in table 4. The obtained correlation 
coefficients for LRT, FEX, DES, LCT, PRZ and CIN was>0.9 that 
indicated high linearity over the entire concentration range.  
The accuracy of the method was tested at three concentration levels 
of 80, 100 and 120 % of the expected assay value of the marketed 
formulation. The % recovery of LRT, FEX, DES, LCT, PRZ and CIN (n = 
3) and mean % recovery (n = 9) were determined, and data are 
presented in table 4. The recoveries of LRT, FEX, DES, LCT, PRZ and 
CIN at each level were found to lie within the acceptable criteria of 
the bias 2 %. The method precision was evaluated by injecting six 
replicates of LRT, FEX, DES, LCT, PRZ and CIN at three concentration 
levels for intra-and inter-day precision and the results were 
expressed as % RSD. The results are summarized in table 4. Limit of 
detection (LOD) and limit of quantification (LOQ) values for LRT, 
FEX, DES, LCT, PRZ and CIN were estimated by plotting calibration 
curves at five levels ranging from 0.05 to 1.0 % of the nominal 
concentration, and the values are presented in table 4. The stock and 
the sample solutions were stable throughout the period of study (30 
d). No significant degradation was found within the period of 
evaluation, indicating that solutions are stable. Peak areas of all the 
analytes were almost identical to that obtained during initially 
prepared solutions, and additional peaks were not observed.  
The robustness of the method was evaluated from CCD experiments 
data. When the ACN content of mobile phase was increased above 
3.2%, a significant decrease in the retention factor was observed. 
Increasing ACN content and decreasing pH negatively affected the 
resolution between Rs5,6. Increasing ACN content, decreasing pH and 
increasing the flow rate reduced the run time of the method. 
However, the method was more robust within the normal operating 
range, i.e., % ACN, 19.88±0.7 % v/v (factor A); pH, 4±0.02 (factor B) 
and flow rate, 1.0±0.05 ml/min (factor C), demonstrating the 
robustness of the method. 
  
Table 4: Summary of validation report 
Validation parameters Analytes 
LOR FEX DES LCT PRZ CIN 
Linearity 2-10 µg/ml 5-25 µg/ml 2-10 µg/ml 2-10 µg/ml 4-20 µg/ml 5-50 µg/ml 
Results 𝑦
















r2 0.992 0.995 0.994 0.995 0.998 0.999 
LOD 1.51 ng/ml 5.32 ng/ml 8.51 ng/ml 1.77 ng/ml 4.04 ng/ml 5.57 ng/ml 
LOQ 4.60 ng/ml 16.05 ng/ml 25.81 ng/ml 5.37 ng/ml 12.24 ng/ml 16.90 ng/ml 
Specificity The method is specific with respect to tablets ingredients 
Accuracy Mean Recovery±SD(%), (n = 3) 
at 80% 101.02±0.16 100.37±0.58 101.41±0.28 100.60±0.09 102.29±0.07 102.35±0.04 
at 100% 99.85±0.97 101.00±0.01 100.30±0.19 101.47±0.13 99.82±0.02 99.83±0.03 
at 120% 99.67±0.55 98.61±0.39 98.99±0.29 98.68±0.05 99.02±0.04 99.02±0.04 
 Mean recovery±SD(%), (n = 9) 
 100.18±0.85 99.99±1.12 100.23±1.07 100.25±1.23 100.37±1.47 100.40±1.50 
Precision n=6 
a. Intraday Conc. %RSD Conc. %RSD Conc. %RSD Conc. %RSD Conc. %RSD Conc. %RSD 
 2µg 2.44 5µg 2.65 2µg 2.80 2µg 1.11 4µg 2.31 5µg 0.95 
 6µg 1.28 15µg 2.49 6µg 1.30 6µg 1.04 12µg 1.18 25µg 1.02 
 10 µg 1.78 25µg 2.14 10µg 1.30 10 µg 1.23 20µg 2.10 50µg 0.82 
b. Interday Conc. %RSD Conc. %RSD Conc. %RSD Conc. %RSD Conc. %RSD Conc. %RSD 
 2µg 2.48 5µg 2.44 2µg 2.78 2µg 1.10 4µg 2.24 5µg 0.84 
 6µg 1.32 15µg 2.32 6µg 1.31 6µg 1.02 12µg 1.21 25µg 1.32 
 10 µg 1.82 25µg 2.12 10µg 1.34 10 µg 1.24 20µg 2.08 50µg 0.96 
Robustness Variations did not alter response more than 2% and therefore it could be concluded that the method conditions are 
robust. 
 
Application of the developed method 
To assess the applicability of the developed method for intended 
purpose, an attempt was made to determine the content of LRT, 
FEX, DES, LCT, PRZ and CIN in commercially available tablets. 
For the assay, the sample solution was prepared as described 
under section “Preparation of sample solution”. The assay 
results are summarized in table 5. From table 5, it can be seen 
that the recoveries of cited antihistamines from tablets were 
high (% recovery), consistent (low %RSD) and agreed with the 
label claim of corresponding marketed formulations. The 
obtained results demonstrate high accuracy and reproducibility 
of the proposed method. A typical chromatogram of tablet 
analysis is shown in fig. 5(c). 
  
Table 5: Assay data for quality control of marketed formulation 
 Product Drug Label claim Found %RSD 
1. Lorfast Meltabs LOR 5 mg 4.99±0.02 1.28 
2. Allegra 120 tab FEX 120 mg 119.4±0.01 2.14 
3. Deslor 5 mg DES 5 mg 4.97±0.02 1.30 
4. Vozet 5 mg tab LCT 5 mg 4.99±0.02 1.04 
5. Phenergan 10 mg tab PRZ 10 mg 9.98±0.02 1.18 
6. Stugeron 25 mg tab CIN 25 mg 24.99±0.02 1.02 
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Fig. 5: Representative overlaid chromatograms corresponding to (a) placebo solution (b) laboratory made mixtures and (c) marketed 
tablet dosage forms as per elution order: loratadine (LRT), fexofenadine (FEX), desloratadine (DES), doxylamine (IS), levocetirizine (LCT), 
promethazine (PRZ) and cinnarizine (CIN) under optimum condition 
 
CONCLUSION  
In this paper a simple, rapid, and efficient RP-HPLC method was 
developed, optimized and validated for the simultaneous 
determination of the LRT, FEX, DES, LCT, PRZ, CIN and DOX (IS). 
Time of analysis, resolution, and quality of the peaks were optimized by 
applying useful tools of chemometrics: fractional factorial design, central 
composite design and global optimization technique (Derringer’s 
desirability function). The results of the study demonstrated the benefit 
of applying chemometric tools in selecting optimum conditions for the 
determinations of cited drugs in pharmaceutical formulations. This 
method reduced overall assay development time and provided essential 
information regarding the sensitivity of various chromatographic 
variables on separation attributes. The validation study supported the 
selection of the assay conditions by confirming that the assay was 
accurate, linear, precise and robust. Therefore, it could be successfully 
adopted for routine quality control of cited antihistaminic drugs in bulk 
drug and pharmaceutical formulations. 
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